powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1558517904
Kelly Wentworth
MD
Internal Medicine
San Francisco,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
97.3
Quality
89.9
Cost
78.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.94%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
75
Beneficiaries
—
Total drug cost
$514K
Distinct drugs
4
Brand share
52.0%
Top prescribed drugs
Burosumab-Twza
28 claims
Teriparatide
19 claims
Testosterone
17 claims
Abaloparatide
11 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$61
Payment records
1
By payment type
Education
$61
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
13
Unique beneficiaries
—
Total services
16
Distinct HCPCS
1
Medicare payment
$1K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 10,499 Internal Medicine providers in CA — bottom quintile (cohort median 531).